Both in Pharmaceuticals
Vistagen Therapeutics vs Lantern Pharma
Over the past year VTGN returned −95.6% and LTRN returned −84.0%; their daily moves had a correlation of 0.09.
VTGN −95.6% LTRN −84.0%Growth of $1, one year, split-adjusted
| Metric | VTGN | LTRN |
|---|---|---|
| Price | $0.1978 | $0.6564 |
| Market cap | $8.8M | $9.8M |
| Today | −2.61% | +2.35% |
| 1 month | −15.1% | −56.2% |
| 6 months | −67.3% | −75.5% |
| Year to date | −70.1% | −78.3% |
| 1 year | −95.1% | −83.5% |
| Revenue growth (YoY) | +504.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −882.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.5× | — |
| Net cash | $31.7M | $7.4M |
| Dividend yield | — | — |
| Volatility (60d) | 115.0% | 81.4% |
| Short % of float | 8.7% | 4.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).